![Cancers | Free Full-Text | Gene Expression Signatures of a Preclinical Mouse Model during Colorectal Cancer Progression under Low-Dose Metronomic Chemotherapy | HTML Cancers | Free Full-Text | Gene Expression Signatures of a Preclinical Mouse Model during Colorectal Cancer Progression under Low-Dose Metronomic Chemotherapy | HTML](https://www.mdpi.com/cancers/cancers-13-00049/article_deploy/html/images/cancers-13-00049-g004.png)
Cancers | Free Full-Text | Gene Expression Signatures of a Preclinical Mouse Model during Colorectal Cancer Progression under Low-Dose Metronomic Chemotherapy | HTML
![Cancers | Free Full-Text | Gene Expression Signatures of a Preclinical Mouse Model during Colorectal Cancer Progression under Low-Dose Metronomic Chemotherapy | HTML Cancers | Free Full-Text | Gene Expression Signatures of a Preclinical Mouse Model during Colorectal Cancer Progression under Low-Dose Metronomic Chemotherapy | HTML](https://www.mdpi.com/cancers/cancers-13-00049/article_deploy/html/images/cancers-13-00049-g001.png)
Cancers | Free Full-Text | Gene Expression Signatures of a Preclinical Mouse Model during Colorectal Cancer Progression under Low-Dose Metronomic Chemotherapy | HTML
![Clinical and molecular characteristics of estrogen receptor‐positive ultralow risk breast cancer tumors identified by the 70‐gene signature - Johansson - 2022 - International Journal of Cancer - Wiley Online Library Clinical and molecular characteristics of estrogen receptor‐positive ultralow risk breast cancer tumors identified by the 70‐gene signature - Johansson - 2022 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1332ad61-1612-4599-87d3-f24b3014c44f/ijc33969-toc-0001-m.jpg)
Clinical and molecular characteristics of estrogen receptor‐positive ultralow risk breast cancer tumors identified by the 70‐gene signature - Johansson - 2022 - International Journal of Cancer - Wiley Online Library
![Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia | Science Translational Medicine Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.aaz0463/asset/2de8d51f-e528-4c0f-b870-65c5ac0852f7/assets/graphic/aaz0463-f1.jpeg)
Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia | Science Translational Medicine
![Cancers | Free Full-Text | Gene Expression Signatures of a Preclinical Mouse Model during Colorectal Cancer Progression under Low-Dose Metronomic Chemotherapy | HTML Cancers | Free Full-Text | Gene Expression Signatures of a Preclinical Mouse Model during Colorectal Cancer Progression under Low-Dose Metronomic Chemotherapy | HTML](https://www.mdpi.com/cancers/cancers-13-00049/article_deploy/html/images/cancers-13-00049-ag-550.jpg)
Cancers | Free Full-Text | Gene Expression Signatures of a Preclinical Mouse Model during Colorectal Cancer Progression under Low-Dose Metronomic Chemotherapy | HTML
![PDF] The impact of inter-observer variation in pathological assessment of node-negative breast cancer on clinical risk assessment and patient selection for adjuvant systemic treatment PDF] The impact of inter-observer variation in pathological assessment of node-negative breast cancer on clinical risk assessment and patient selection for adjuvant systemic treatment](https://i1.rgstatic.net/publication/26686178_The_impact_of_inter-observer_variation_in_pathological_assessment_of_node-negative_breast_cancer_on_clinical_risk_assessment_and_patient_selection_for_adjuvant_systemic_treatment/links/56a8c3e608ae860e02577b7a/largepreview.png)
PDF] The impact of inter-observer variation in pathological assessment of node-negative breast cancer on clinical risk assessment and patient selection for adjuvant systemic treatment
![Transcriptomic analyses of MYCN-regulated genes in anaplastic Wilms' tumour cell lines reveals oncogenic pathways and potential therapeutic vulnerabilities | bioRxiv Transcriptomic analyses of MYCN-regulated genes in anaplastic Wilms' tumour cell lines reveals oncogenic pathways and potential therapeutic vulnerabilities | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/01/11/2021.01.11.426177/F5.large.jpg)
Transcriptomic analyses of MYCN-regulated genes in anaplastic Wilms' tumour cell lines reveals oncogenic pathways and potential therapeutic vulnerabilities | bioRxiv
![Cancers | Free Full-Text | Gene Expression Signatures of a Preclinical Mouse Model during Colorectal Cancer Progression under Low-Dose Metronomic Chemotherapy | HTML Cancers | Free Full-Text | Gene Expression Signatures of a Preclinical Mouse Model during Colorectal Cancer Progression under Low-Dose Metronomic Chemotherapy | HTML](https://www.mdpi.com/cancers/cancers-13-00049/article_deploy/html/images/cancers-13-00049-g003.png)